SGD Pharma leads the charge towards greater sustainability and innovation by highlighting its multi-million investments into the next-generation of glass manufacturing and commitment to strengthening pharma supply chains in the US and beyond.
DCAT Week takes place between March 17 and 20, 2025 and is one of the most influential gatherings for pharmaceutical and biotech companies from across the world, providing a powerful platform for high-level discussions, networking and collaboration with key industry leaders.
Fabio Invernizzi, General Manager BU West, and Carole Grassi Mircich, Chief Commercial Marketing & Innovation Officer, will be attending to support SGD Pharma’s US team in strategic discussions.
Carole added, “I am excited to attend DCAT Week and reconnect with our valued customers and partners. We are eager to dive deep into understanding their evolving needs, showcase our cutting-edge innovations, and explore new opportunities for collaboration that will drive the future of our industry.”